Table 2.

Comparison of basic clinical data of the two groups in pregnant women.

Indicators	GDM group (n = 142)	Normal group (n = 442)	t /Z value	P -value
Age (y)*	30.38 ± 4.33	29.08 ± 4.31	3.130	0.002
Pre-pregnancy BMI (kg/m2)	23.29 (21.38, 27.1)	20.1 (19.2, 21.2)	11.37	0.000
PT (s)	11.7 (11.2, 12.1)	11.9 (11.6, 12.2)	3.186	0.001
INR	0.99 (0.95, 1.03)	1.01 (0.98, 1.04)	3.269	0.001
APTT (s)*	26.92 ± 1.75	28.12 ± 1.86	−6.767	0.000
FIB (g/L)	3.933 (3.588, 4.421)	3.784 (3.362, 4.202)	3.583	0.000
TT (s)	15.5 (15.125, 15.9)	15.8 (15.4, 16.2)	5.153	0.000
D-Dimer (mg/L)	0.54 (0.40, 0.77)	0.50 (0.36, 0.70)	2.109	0.035
FDP (mg/L)	2.5 (2.5, 3.09)	2.5 (2.5, 2.72)	2.850	0.004
FPG (mmol/L)	4.965 (4.675, 5.218)	4.7 (4.5, 4.93)	7.237	0.000
TC (mmol/L)	5.31 (4.58, 5.85)	4.85 (4.35, 5.487)	3.655	0.000
TG (mmol/L)	1.91 (1.54, 2.31)	1.55 (1.25, 1.89)	6.403	0.000
HDL- (mmol/L)	1.7 (1.51, 1.92)	1.73 (1.53, 1.928)	0.477	0.634
LDL-C (mmol/L)	2.85 (2.49, 3.34)	2.61 (2.31, 3.018)	4.831	0.000
sdLDL-C (mg/L)	418.3 (346.75, 485.975)	344.15 (291.85, 392.1)	7.492	0.000
APOA-1 (g/L)*	1.73 ± 0.25	1.71 ± 0.23	0.909	0.364
APOB (g/L)	0.95 (0.82, 1.08)	0.88 (0.79, 0.987)	3.693	0.000
APOE (mg/L)	44 (38, 52)	40 (34, 49)	4.445	0.000
LPa (mg/dL)	14.3 (8.9, 29.6)	13.9 (8.67, 25.72)	0.970	0.332

BMI, body mass index; PT, prothrombin time; INR, international standardized ratio; APTT, activated partial thromboplastin time; FIB, fibrinogen; TT, thrombin time; D-Dimer, D-dimer determination; FDP, fibrin degradation products; FPG, fasting blood glucose; TC, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein; LDL-C, low density lipoprotein; sdLDL-C, small and low density Density lipoprotein cholesterol; APOA-1, Apolipoprotein A1; APOB, Apolipoprotein B; APOE, Apolipoprotein E; LPa, Lipoprotein (a);

^*The results of normality test showed that the observed variables were close to normal distribution in each group.